Company
Nuvig Therapeutics
Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases
Also known as Nuvig, Nuvig Therapeutics, Inc.
- Business model
- B2B
- Customers
- patients with autoimmune disease
- Legal name
- Nuvig Therapeutics, Inc.
- nuvigtherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Nuvig Therapeutics, our mission is to change the treatment paradigm for patients with autoimmune disease. We acknowledge the urgent need to provide next-generation immune modulators that treat the underlying inflammatory disease without compromising immune function.
Funding snapshot
- Total raised
- $161MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $161M2024-12-05
Funding rounds
- Series B
- $161M2024-12-05, Company stated
Products
- Other
- NVG-2089
- Web
- NVG-2089
Loading relationship preview